Dr Rahamatullah Shaikh
School of Pharmacy and Medical Sciences
(Faculty of Life Sciences)
Dr. Rahamatullah Shaikh is a Pharmacist and Assistant Professor in Industrial Pharmaceutics in the Centre for Pharmaceutical Engineering Science at the School of Pharmacy and Medical Sciences, University of Bradford. Dr. Rahamat has diverse international research experience in academia and pharmaceutical industry including drug formulation development, optimization, delivery, continuous pharmaceutical manufacturing, particle engineering, powder characterisation, process analytical technologies and pharmaceutical analysis. He obtained his PhD in 2020, under the supervision of Prof. Gavin Walker at Synthesis and Solid-State Pharmaceutical Centre (SSPC), University of Limerick, Ireland with a Thesis entitled "Continuous mechanochemical preparation and formulation of pharmaceutical cocrystals and it’s solid processing”. He subsequently worked as a postdoctoral research assistant at the University of Limerick investigating continuous processing of pharmaceutical cocrystal drug products as part of the SFI funded SSPC. During his MPhil at the School of Pharmacy, Queen’s University Belfast, UK, he formulated novel bucco-adhesive buccal patches intended for clinical application for mouth ulcers, in an industry-sponsored project. His developed formulation has been patented.
He is the author of more than 11 peer-reviewed publications (including in Trends. Pharmacol. Sci. - IF 17.6) and currently has a h-index of 9 with total of 969 citations. He has also contributed a book chapter on “The development of a pharmaceutical oral solid dosage forms” to highly regarded book Computer Aided Chemical Engineering (vol. 41) published by Elsevier. He is a regular reviewer for a number of journals including Int. J. Pharm., Cryst. Growth. Des., and J. Mol. Liq. He also acted as a Guest Editor for Pharmaceutics-MDPI.
Dr. Rahamat’s teaching philosophy is to generate curiosity in his students to develop their own critical thinking skills. They learn best when given the opportunity to satisfy it by being exposed to new ideas and testing these ideas to explore new knowledge or to solve real problems. He is passionate about helping his students become successful pharmacists and researcher. He experienced in lecturing at the University of Limerick, contributing to various chemistry modules within the department of Chemical Sciences. He was a module coordinator for CH4554 and involved in instructing CH4354, CH4303 and CH4304 modules. During this tenure he gained expertise in blended learning delivery. He has involved in 16 project supervision to both FYPs, MPharm (stage four projects) and visiting international students.
He is actively involved in community outreach and education, he strives to bring science to a wider audience, including his previous roles as outreach working group at SSPC (University of Limerick), where he hosted schools on campus or went out to science events in schools (for example, spectroscopy in a suitcase). He also volunteered to support the department’s outreach activities, like Limerick engineering programme.
Dr. Rahamat teaches Pharmaceutics at University of Bradford across the undergraduate and postgraduate programmes namely: MPharm and MSc Pharmaceutical Technology and Medicines Control and supervises a range of MPharm and MSc Pharm Tech research projects. He is the Health and Safety Lead at the Centre for Pharmaceutical Engineering Science.
ResearchDr. Rahamat’s research focuses on the interface between industrial pharmacy, material science, and chemistry. The primary aim of our research is to design, develop, and industrially translate next-generation drug delivery technologies for improving therapeutic efficacy and patient compliance.
His research program has three main broad focus areas:
1. Development of continuous manufacturing processes for drug products via a quality by design (QbD) approach to define mechanistic factors that influence the performance of drug products.
2. Design and development of new techniques for drug delivery including oral, mucosal, transdermal, and ophthalmic systems to treat a range of illnesses.
3. Designing novel biomaterials to enable new applications in drug delivery and regenerative medicine.